Home
>
National Drug Code (NDC)
>
Alfuzosin Hydrochloride
Alfuzosin Hydrochloride - 0378-5005-05 - (alfuzosin)
Drug Information of Alfuzosin Hydrochloride
| Product NDC: | 0378-5005 |
| Proprietary Name: | Alfuzosin Hydrochloride |
| Non Proprietary Name: | alfuzosin |
| Active Ingredient(s): | 10 mg/1 & nbsp; alfuzosin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Alfuzosin Hydrochloride
| Product NDC: | 0378-5005 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079014 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130507 |
Package Information of Alfuzosin Hydrochloride
| Package NDC: | 0378-5005-05 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-5005-05) |
NDC Information of Alfuzosin Hydrochloride
| NDC Code | 0378-5005-05 |
| Proprietary Name | Alfuzosin Hydrochloride |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-5005-05) |
| Product NDC | 0378-5005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alfuzosin |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130507 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ALFUZOSIN HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
